These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 21572328)

  • 1. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
    Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
    Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
    Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin increase in early identification of critically ill patients at high risk of mortality.
    Jensen JU; Heslet L; Jensen TH; Espersen K; Steffensen P; Tvede M
    Crit Care Med; 2006 Oct; 34(10):2596-602. PubMed ID: 16915118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.
    Jensen JU; Lundgren B; Hein L; Mohr T; Petersen PL; Andersen LH; Lauritsen AO; Hougaard S; Mantoni T; Bømler B; Thornberg KJ; Thormar K; Løken J; Steensen M; Carl P; Petersen JA; Tousi H; Søe-Jensen P; Bestle M; Hestad S; Andersen MH; Fjeldborg P; Larsen KM; Rossau C; Thomsen CB; Ostergaard C; Kjaer J; Grarup J; Lundgren JD
    BMC Infect Dis; 2008 Jul; 8():91. PubMed ID: 18620598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
    Heyland DK; Johnson AP; Reynolds SC; Muscedere J
    Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A letter in response to: Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
    Diaz-Flores RF
    Crit Care Med; 2012 Mar; 40(3):1038; author reply 1038-9. PubMed ID: 22343883
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.
    Daneman N; Rishu AH; Xiong W; Bagshaw SM; Cook DJ; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Stelfox HT; Fowler RA;
    Trials; 2015 Apr; 16():173. PubMed ID: 25903783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.